CoviCept Therapeutics

PharmaceuticalsSeedSan Diego, US

Latest round

Seed

Last raised

Jan 2021

Total raised

$2.3M

Investors

1

About CoviCept Therapeutics

, producer of a small molecule intended to restrain the spread of RNA viruses, including SARS-Cov-2. In January 2021, CoviCept Therapeutics, Inc. CoviCept Therapeutics, Inc offers a small molecule drug designed to interfere with a host cell protein that is essential for the replication of RNA viruses. By targeting a host factor rather than the virus directly, the approach reduce the resistance developing through viral mutation. The compound has demonstrated the ability to inhibit SARS-CoV-2 replication in preclinical animal models and has shown activity against other RNA viruses, including zika and dengue. The compound has also completed Phase 1 clinical trials. In October 2021, CoviCept initiated a Phase 2 clinical trial of SARS-CoV-2 and other RNA viruses.

Who invested in CoviCept Therapeutics

1 investor across 1 round

See all investors in CoviCept Therapeutics

Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.

Funding rounds

  1. Seed

    Jan 19, 2021

    Amount

    $2.3M

    Investors

    Locked

Questions about CoviCept Therapeutics

Who invested in CoviCept Therapeutics?

CoviCept Therapeutics has 1 investor on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.

How much funding has CoviCept Therapeutics raised?

CoviCept Therapeutics has raised 1 venture round. Sign up free to see how much each round raised and the total.

When did CoviCept Therapeutics last raise money?

CoviCept Therapeutics's most recent round on record is a Seed, in Jan 2021.

What does CoviCept Therapeutics do?

, producer of a small molecule intended to restrain the spread of RNA viruses, including SARS-Cov-2.

Where is CoviCept Therapeutics headquartered?

CoviCept Therapeutics is headquartered in San Diego, US.

Which VCs invest in companies like CoviCept Therapeutics?

Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back pharmaceuticals companies at CoviCept Therapeutics's stage. Their profiles are linked below.

Raising like CoviCept Therapeutics? Find the right VCs.

Capital Atlas matches your startup to active investors by stage, sector and region.

Free to start. Upgrade when you're ready to reach out.